MP:0001144 | fused vaginal opening | "condition in which the external vaginal opening is closed by the adherence of the epithelium of the vagina" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Dhx58tm1Aki/Dhx58tm1Aki Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0002410 | decreased susceptibility to viral infection | "reduced likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0002418 | increased susceptibility to viral infection | "greater likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
Allelic Composition: Dhx58tm1Aki/Dhx58tm1Aki Genetic Background: involves: 129/Sv * C57BL/6
Allelic Composition: Dhx58tm2.1Aki/Dhx58tm2.1Aki Genetic Background: involves: 129/Sv * C57BL/6
Allelic Composition: Dhx58tm1Itl/Dhx58tm1Itl Genetic Background: C57BL/6-Dhx58tm1Itl
|
MP:0004906 | enlarged uterus | |
Show
Allelic Composition: Dhx58tm1Aki/Dhx58tm1Aki Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0005025 | response to infection | "the body s reaction to invasion and multiplication of microorganisms in its tissues, or the body s reaction to components of or toxins produced by pathogenic mircroorganisms " [MeSH:National Library of Medicine - Medical Subject Headings , 2003, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0006413 | increased T cell apoptosis | "increase in the number of T cells undergoing programmed cell death" [MGI:brs "Beverly Richards-Smith, Mouse Genome Informatics Curator", MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Dhx58tm1Itl/Dhx58tm1Itl Genetic Background: C57BL/6-Dhx58tm1Itl
|
MP:0008555 | abnormal interferon secretion | "anomaly in the production or release of proteins secreted by vertebrate cells in response to a wide variety of inducers; they confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions" [MESH:D12.644.276.374.440] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0008561 | decreased tumor necrosis factor secretion | "reduction in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Dhx58tm1Itl/Dhx58tm1Itl Genetic Background: C57BL/6-Dhx58tm1Itl
|
MP:0008562 | increased interferon-alpha secretion | "increase in the production or release of one of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells that has antiviral activity and activates natural killer cells and B cells" [MESH:D12.644.276.374.440.890.250] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0008563 | decreased interferon-alpha secretion | "increase in the production or release of one of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells that has antiviral activity and activates natural killer cells and B cells" [MESH:D12.644.276.374.440.890.250] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0008564 | increased interferon-beta secretion | "increase in the production or release of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0008565 | decreased interferon-beta secretion | "reduction in the production or release of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
Allelic Composition: Dhx58tm1Aki/Dhx58tm1Aki Genetic Background: involves: 129/Sv * C57BL/6
Allelic Composition: Dhx58tm2.1Aki/Dhx58tm2.1Aki Genetic Background: involves: 129/Sv * C57BL/6
Allelic Composition: Dhx58tm1Itl/Dhx58tm1Itl Genetic Background: C57BL/6-Dhx58tm1Itl
|
MP:0008567 | decreased interferon-gamma secretion | "reduction in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Dhx58tm1Itl/Dhx58tm1Itl Genetic Background: C57BL/6-Dhx58tm1Itl
|
MP:0008576 | decreased circulating interferon-beta level | "reduction in the amount in the blood of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Dhx58tm1Aki/Dhx58tm1Aki Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008577 | increased circulating interferon-gamma level | "increase in the amount in the blood of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0008617 | increased circulating interleukin-12 level | "increase in the amount in the blood of a heterodimeric cytokine that plays a role in innate and adaptive immune responses; it is produced by dendritic cells, macrophages and a variety of other immune cells and plays a role in the stimulation of interferon-gamma production by T-cells and natural killer cells" [MESH:D12.644.276.374.465.512] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0008706 | decreased interleukin-6 secretion | "reduction in the production or release of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Dhx58tm1Aki/Dhx58tm1Aki Genetic Background: involves: 129/Sv * C57BL/6
Allelic Composition: Dhx58tm2.1Aki/Dhx58tm2.1Aki Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0009763 | increased sensitivity to induced morbidity/mortality | "decrease in the amount of an external agent required to cause death or diseased state" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0009764 | decreased sensitivity to induced morbidity/mortality | "increase in the amount of an external agent required to cause death or diseased state" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Il6sttm1Wme/Il6sttm1Wme,Tg(Alb1-cre)7Gsc/? Genetic Background: involves: 129P2/OlaHsd * FVB/N
|
MP:0009791 | increased susceptibility to viral infection induced morbidity/mortality | "increased likelihood that an organism will display the expected moribund state caused by a viral invasion or from components of or toxins produced by a virus" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Dhx58tm1Aki/Dhx58tm1Aki Genetic Background: involves: 129/Sv * C57BL/6
Allelic Composition: Dhx58tm2.1Aki/Dhx58tm2.1Aki Genetic Background: involves: 129/Sv * C57BL/6
Allelic Composition: Dhx58tm1Itl/Dhx58tm1Itl Genetic Background: C57BL/6-Dhx58tm1Itl
|
MP:0011101 | partial prenatal lethality | "the appearance of lower than Mendelian ratios of organisms of a given genotype due to death of some, but not all of the organisms between fertilization and birth (Mus: approximately E18.5)" [MGI:csmith] |
Show
Allelic Composition: Dhx58tm1Aki/Dhx58tm1Aki Genetic Background: involves: 129/Sv * C57BL/6
|